SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FAINARDI, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.390
AS - Asia 6.224
EU - Europa 3.655
SA - Sud America 929
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 23.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.175
SG - Singapore 2.664
CN - Cina 1.876
BR - Brasile 801
DE - Germania 633
IT - Italia 626
UA - Ucraina 621
HK - Hong Kong 573
GB - Regno Unito 448
TR - Turchia 393
VN - Vietnam 334
PL - Polonia 309
FI - Finlandia 278
SE - Svezia 198
RU - Federazione Russa 179
CA - Canada 105
MX - Messico 92
ID - Indonesia 83
FR - Francia 73
IN - India 67
ZA - Sudafrica 59
BE - Belgio 55
AR - Argentina 50
AT - Austria 50
BD - Bangladesh 43
JP - Giappone 43
NL - Olanda 34
CZ - Repubblica Ceca 33
ES - Italia 29
IQ - Iraq 26
LT - Lituania 24
EC - Ecuador 20
CO - Colombia 17
IR - Iran 17
PK - Pakistan 16
MA - Marocco 14
PY - Paraguay 14
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
EG - Egitto 9
KE - Kenya 9
NO - Norvegia 9
UY - Uruguay 9
AU - Australia 8
PT - Portogallo 8
A2 - ???statistics.table.value.countryCode.A2??? 7
KR - Corea 7
RO - Romania 7
SA - Arabia Saudita 7
VE - Venezuela 7
EU - Europa 6
IE - Irlanda 6
PE - Perù 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CH - Svizzera 5
NP - Nepal 5
PH - Filippine 5
CL - Cile 4
DZ - Algeria 4
GR - Grecia 4
HN - Honduras 4
IL - Israele 4
KZ - Kazakistan 4
AO - Angola 3
ET - Etiopia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
NG - Nigeria 3
OM - Oman 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AL - Albania 2
AM - Armenia 2
DO - Repubblica Dominicana 2
GD - Grenada 2
HR - Croazia 2
HU - Ungheria 2
LU - Lussemburgo 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
KG - Kirghizistan 1
Totale 23.323
Salva come PNG Salva come JPEG
Città #
Singapore 1.475
Woodbridge 1.338
Ashburn 1.306
Fairfield 1.093
Chandler 768
Houston 733
Jacksonville 676
Beijing 626
Santa Clara 615
Hong Kong 573
Ann Arbor 561
Wilmington 395
Seattle 385
Cambridge 360
Warsaw 296
Izmir 234
Los Angeles 234
New York 224
Nanjing 219
Dallas 205
Ferrara 194
Princeton 180
Munich 146
Milan 145
Boardman 122
Ho Chi Minh City 115
Shanghai 112
San Diego 90
Addison 81
São Paulo 81
Dearborn 80
Helsinki 71
Hanoi 67
Nanchang 67
Turku 66
Mexico City 65
Shenyang 63
Buffalo 62
Bremen 59
Jakarta 59
Brooklyn 56
Brussels 55
The Dalles 54
London 53
Tianjin 51
Chicago 50
Jiaxing 50
Changsha 46
Hebei 46
Montreal 44
Hefei 43
Tokyo 42
Stockholm 41
Denver 40
Norwalk 38
Poplar 36
Atlanta 34
Vienna 34
Orem 33
Chennai 32
Falls Church 32
Johannesburg 32
Toronto 30
Brno 29
Phoenix 29
San Mateo 28
Boston 27
Ningbo 26
Rio de Janeiro 26
San Francisco 26
Jinan 24
Ankara 23
Orange 23
Redwood City 23
Zhengzhou 23
Bologna 22
Moscow 22
Auburn Hills 21
Columbus 21
Falkenstein 21
Nuremberg 21
Frankfurt am Main 19
Kunming 19
Rome 19
Guangzhou 18
Mountain View 18
Curitiba 17
Brasília 16
Verona 16
Dong Ket 15
Taizhou 15
Tappahannock 15
Belo Horizonte 14
Biên Hòa 14
Haiphong 14
Manchester 14
San Jose 14
Amsterdam 13
Charlotte 13
Des Moines 13
Totale 15.944
Salva come PNG Salva come JPEG
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 387
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 238
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 221
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 214
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 212
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 212
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 210
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 208
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 204
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 203
HLA-G Molecules in Autoimmune Diseases and Infections 202
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 201
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 199
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 197
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 196
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 196
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 196
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 195
Emerging topics and new perspectives on HLA-G 189
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 187
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 183
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 183
Survival prediction in high-grade gliomas using CT perfusion imaging 181
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 181
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 180
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 178
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 178
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 175
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 171
Leptin/adiponectin ratio predicts post-stroke neurological outcome 169
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 168
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 166
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 166
Cerebrospinal fluid analysis and the determination of oligoclonal bands 166
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 164
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 163
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 162
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 162
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 162
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 162
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 160
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 158
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 156
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 155
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 153
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 153
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 152
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 151
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 151
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 151
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 151
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 150
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 150
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 150
Some basic aspects of HLA-G biology. 149
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 148
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 147
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 146
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 146
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 143
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 143
New insights into HLA-G and inflammatory diseases 142
Neurofilament ELISA validation 142
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 141
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 141
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 140
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 139
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 138
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 137
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 136
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 136
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 133
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 132
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 132
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 130
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 130
Le catene leggere libere liquorale sclerosi multipla 129
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 128
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 127
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 126
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 126
Congruence between clinical diagnosis and DATSCAN imaging in 150 consecutive patients. 124
Role of Toll-like receptors in patients with multiple sclerosis and Chlamydophila pneumoniae infection 124
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 124
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 124
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 124
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 124
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 124
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 123
Cerebrospinal fluid free Kappa and Lambda lights chains in MS. A qualitative analysis 121
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 121
null 121
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 115
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 114
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 114
Endovascular Thrombectomy for Acute Ischemic Stroke beyond 6 Hours from Onset: A Real-World Experience 113
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 112
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 112
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 111
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 111
Totale 15.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.001
Totale 116.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.214 0 0 0 0 0 178 64 221 70 270 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20254.035 103 92 310 158 530 353 98 156 767 477 567 424
2025/20266.173 1.131 456 853 1.429 1.707 597 0 0 0 0 0 0
Totale 23.628